Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Convalescent plasma is a leading treatment for coronavirus disease 2019 (COVID-19), but there is a paucity of data identifying its therapeutic efficacy. Among 126 potential convalescent plasma donors, the humoral immune response was evaluated using a severe acute respiratory syndrome coronavirus 2 (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: Klein, Sabra L., Pekosz, Andrew, Park, Han-Sol, Ursin, Rebecca L., Shapiro, Janna R., Benner, Sarah E., Littlefield, Kirsten, Kumar, Swetha, Naik, Harnish Mukesh, Betenbaugh, Michael J., Shrestha, Ruchee, Wu, Annie A., Hughes, Robert M., Burgess, Imani, Caturegli, Patricio, Laeyendecker, Oliver, Quinn, Thomas C., Sullivan, David, Shoham, Shmuel, Redd, Andrew D., Bloch, Evan M., Casadevall, Arturo, Tobian, Aaron A.R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7598041/
https://ncbi.nlm.nih.gov/pubmed/32764200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI142004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados